APTO Aptose Biosciences Inc
Price (delayed)
$1.71
Market cap
$4.36M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$36.38
Enterprise value
$8.3M
Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics
Highlights
The quick ratio has soared by 146% YoY and by 83% from the previous quarter
The EPS has surged by 84% year-on-year and by 59% since the previous quarter
Aptose Biosciences's equity has shrunk by 57% YoY but it has surged by 50% QoQ
Key stats
What are the main financial stats of APTO
Market
Valuations
Earnings
Shares outstanding
2.55M
Market cap
$4.36M
Enterprise value
$8.3M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$26.26M
Net income
-$25.43M
EBIT
-$25.22M
EBITDA
-$24.82M
Free cash flow
-$35.96M
Per share
Balance sheet
Liquidity
EPS
-$36.38
EPS diluted
-$36.38
Free cash flow per share
-$51.44
Book value per share
-$6.98
Revenue per share
$0
TBVPS
$14.49
Total assets
$10.13M
Total liabilities
$14.67M
Debt
$10.64M
Equity
-$4.54M
Working capital
$5.07M
Debt to equity
-2.34
Current ratio
2.14
Quick ratio
1.5
Net debt/EBITDA
-0.16
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-227%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-445%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APTO stock price
How has the Aptose Biosciences stock price performed over time
Intraday
-45.71%
1 week
-50.86%
1 month
-46.39%
1 year
-96.44%
YTD
-74.7%
QTD
-45.71%
Financial performance
How have Aptose Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$26.26M
Net income
-$25.43M
Gross margin
N/A
Net margin
N/A
Aptose Biosciences's net income has soared by 50% YoY and by 29% from the previous quarter
The company's operating income rose by 50% YoY and by 27% QoQ
Growth
What is Aptose Biosciences's growth rate over time
Valuation
What is Aptose Biosciences stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 84% year-on-year and by 59% since the previous quarter
Aptose Biosciences's equity has shrunk by 57% YoY but it has surged by 50% QoQ
Efficiency
How efficient is Aptose Biosciences business performance
The return on assets rose by 24% since the previous quarter but it has declined by 11% year-on-year
Dividends
What is APTO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APTO.
Financial health
How did Aptose Biosciences financials performed over time
The total assets is 31% smaller than the total liabilities
The company's current ratio has surged by 174% YoY and by 104% QoQ
The quick ratio has soared by 146% YoY and by 83% from the previous quarter
APTO's debt to equity has dropped by 100% since the previous quarter
Aptose Biosciences's equity has shrunk by 57% YoY but it has surged by 50% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.